|
1
|
Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G.
|
Hepatology
|
2002
|
2.85
|
|
2
|
Helicobacter pylori in North and South America before Columbus.
|
FEBS Lett
|
2002
|
2.57
|
|
3
|
Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C.
|
Gastroenterology
|
2003
|
2.02
|
|
4
|
Novel nasogastric tube-related criteria for urgent endoscopy in nonvariceal upper gastrointestinal bleeding.
|
Dig Dis Sci
|
2013
|
2.00
|
|
5
|
Hepatitis B virus of genotype B with or without recombination with genotype C over the precore region plus the core gene.
|
J Virol
|
2002
|
1.82
|
|
6
|
Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens.
|
Hepatology
|
2006
|
1.60
|
|
7
|
Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.
|
J Clin Microbiol
|
2005
|
1.53
|
|
8
|
Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.
|
PLoS One
|
2012
|
1.44
|
|
9
|
The first report of successful nasogastric Coca-Cola lavage treatment for bitter persimmon phytobezoars in Japan.
|
Am J Gastroenterol
|
2003
|
1.44
|
|
10
|
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection.
|
J Gastroenterol
|
2004
|
1.43
|
|
11
|
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection.
|
Hepatology
|
2006
|
1.43
|
|
12
|
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas.
|
Hepatol Res
|
2007
|
1.40
|
|
13
|
Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.
|
J Hepatol
|
2006
|
1.40
|
|
14
|
Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F).
|
J Virol
|
2002
|
1.36
|
|
15
|
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality.
|
Gastroenterology
|
2006
|
1.31
|
|
16
|
The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B.
|
J Clin Microbiol
|
2011
|
1.25
|
|
17
|
Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease.
|
J Med Virol
|
2003
|
1.21
|
|
18
|
Exponential spread of hepatitis C virus genotype 4a in Egypt.
|
J Mol Evol
|
2004
|
1.19
|
|
19
|
Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines.
|
J Gen Virol
|
2006
|
1.18
|
|
20
|
Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
|
J Clin Microbiol
|
2007
|
1.14
|
|
21
|
Eight genotypes (A-H) of hepatitis B virus infecting patients from San Francisco and their demographic, clinical, and virological characteristics.
|
J Med Virol
|
2004
|
1.13
|
|
22
|
Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A.
|
J Gen Virol
|
2004
|
1.12
|
|
23
|
A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D.
|
Hepatology
|
2004
|
1.10
|
|
24
|
Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.
|
J Clin Virol
|
2007
|
1.09
|
|
25
|
Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.
|
Liver Int
|
2014
|
1.05
|
|
26
|
Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan.
|
Clin Infect Dis
|
2004
|
1.04
|
|
27
|
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
|
Clin Infect Dis
|
2005
|
1.02
|
|
28
|
Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China.
|
Hepatol Res
|
2002
|
1.02
|
|
29
|
Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism.
|
Hepatol Res
|
2005
|
1.01
|
|
30
|
Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand.
|
J Gastroenterol Hepatol
|
2002
|
0.99
|
|
31
|
Molecular tracing of Japan-indigenous hepatitis E viruses.
|
J Gen Virol
|
2006
|
0.97
|
|
32
|
Improvement of gastric motility by hemodialysis in patients with chronic renal failure.
|
J Smooth Muscle Res
|
2007
|
0.94
|
|
33
|
Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-alpha therapy for patients with chronic hepatitis C.
|
Liver Int
|
2005
|
0.92
|
|
34
|
Accuracy of the Tokyo Guidelines for the diagnosis of acute cholangitis and cholecystitis taking into consideration the clinical practice pattern in Japan.
|
J Hepatobiliary Pancreat Sci
|
2011
|
0.92
|
|
35
|
Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus.
|
J Med Virol
|
2003
|
0.92
|
|
36
|
Genotype and phylogenetic characterization of hepatitis B virus among multi-ethnic cohort in Hawaii.
|
World J Gastroenterol
|
2004
|
0.91
|
|
37
|
A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.
|
J Gastroenterol
|
2007
|
0.91
|
|
38
|
Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection.
|
J Gastroenterol Hepatol
|
2003
|
0.90
|
|
39
|
Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study.
|
J Med Virol
|
2003
|
0.89
|
|
40
|
Measurement of hepatitis B virus core-related antigen as predicting factor for relapse after cessation of lamivudine therapy for chronic hepatitis B virus infection.
|
Hepatol Res
|
2006
|
0.89
|
|
41
|
Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection.
|
Clin Infect Dis
|
2004
|
0.89
|
|
42
|
Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E.
|
World J Gastroenterol
|
2005
|
0.89
|
|
43
|
Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan.
|
J Med Virol
|
2005
|
0.88
|
|
44
|
Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the Cote d'Ivoire: complete genome sequence and phylogenetic relatedness of HBV genotype E.
|
J Med Virol
|
2003
|
0.88
|
|
45
|
Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan.
|
J Hepatol
|
2005
|
0.87
|
|
46
|
Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan.
|
J Infect Dis
|
2003
|
0.87
|
|
47
|
Enterovesical fistula complication in B-cell-type lymphoma of the small intestine.
|
J Gastroenterol
|
2004
|
0.87
|
|
48
|
Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis.
|
Hepatol Res
|
2008
|
0.85
|
|
49
|
Classifying genotype F of hepatitis B virus into F1 and F2 subtypes.
|
World J Gastroenterol
|
2005
|
0.85
|
|
50
|
Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan.
|
J Med Virol
|
2002
|
0.84
|
|
51
|
Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection.
|
J Med Virol
|
2003
|
0.84
|
|
52
|
Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C.
|
Hepatol Res
|
2014
|
0.84
|
|
53
|
Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase support.
|
J Virol Methods
|
2003
|
0.83
|
|
54
|
Hepatitis B virus genotype G is an extremely rare genotype in Japan.
|
Hepatol Res
|
2004
|
0.83
|
|
55
|
Molecular epidemiology of hepatitis B virus in the United Republic of Tanzania.
|
J Med Virol
|
2006
|
0.83
|
|
56
|
Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion.
|
J Gastroenterol
|
2007
|
0.82
|
|
57
|
Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.
|
J Virol
|
2005
|
0.82
|
|
58
|
Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma.
|
Cancer Manag Res
|
2012
|
0.81
|
|
59
|
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation.
|
Antimicrob Agents Chemother
|
2009
|
0.81
|
|
60
|
Novel hepatitis B virus genotype a subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies.
|
J Virol
|
2004
|
0.81
|
|
61
|
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.
|
Hepatol Res
|
2006
|
0.81
|
|
62
|
Development of new IL28B genotyping method using Invader Plus assay.
|
Microbiol Immunol
|
2012
|
0.80
|
|
63
|
Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.
|
J Gastroenterol Hepatol
|
2004
|
0.79
|
|
64
|
Liver transplantation-associated de novo hepatitis B virus infection: application of molecular evolutionary analysis.
|
Intervirology
|
2002
|
0.79
|
|
65
|
Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection.
|
Hepatol Res
|
2008
|
0.78
|
|
66
|
Combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin improves fulminant pseudomembranous colitis by reducing the elevated endogenous cannabinoids and inflammatory cytokines: report of a case.
|
Hepatogastroenterology
|
2008
|
0.77
|
|
67
|
Effects of combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin on fulminant pseudomembranous colitis with septic shock.
|
Dig Dis Sci
|
2007
|
0.77
|
|
68
|
Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.
|
Ther Apher Dial
|
2014
|
0.76
|
|
69
|
A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load.
|
Hepatol Res
|
2004
|
0.76
|
|
70
|
Variations in the viral NS5B region in Japanese patients with chronic hepatitis C virus genotype 1b infection. No specific amino acid substitution was identified as determinants of treatment response to interferon/ribavirin combination therapy.
|
Intervirology
|
2006
|
0.75
|
|
71
|
Accidental exposure to HCV antibody-positive blood in hospital and pre-emptive one-shot interferon alpha-2b treatment.
|
Hepatol Res
|
2007
|
0.75
|
|
72
|
Imatinib plasma levels during successful long-term treatment of metastatic-gastrointestinal stromal tumors.
|
Hepatogastroenterology
|
2014
|
0.75
|
|
73
|
Impaired cytotoxic T lymphocyte inductivity by dendritic cells derived from patients with hepatitis C virus-positive hepatocellular carcinoma.
|
Hepatol Res
|
2007
|
0.75
|
|
74
|
A case of gastrointestinal stromal tumor with internal tandem duplication in the 3'-terminal of the KIT juxtamembrane domain.
|
Dig Dis Sci
|
2005
|
0.75
|
|
75
|
Regression of esophageal papillomatous polyposis caused by high-risk type human papilloma virus.
|
J Gastroenterol
|
2003
|
0.75
|
|
76
|
Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow up.
|
J Gastroenterol Hepatol
|
2003
|
0.75
|